Pharmacy and therapeutics committees strategy to address olmesartan safety issues at a primary care level. [electronic resource]
Producer: 20210304Description: 737-743 p. digitalISSN:- 2210-7711
- Aged
- Aged, 80 and over
- Angiotensin Receptor Antagonists -- adverse effects
- Antihypertensive Agents -- adverse effects
- Celiac Disease -- chemically induced
- Drug Prescriptions -- standards
- Female
- Humans
- Imidazoles -- adverse effects
- Malabsorption Syndromes -- chemically induced
- Male
- Middle Aged
- Pharmacy and Therapeutics Committee -- standards
- Primary Health Care -- methods
- Retrospective Studies
- Risk Factors
- Tetrazoles -- adverse effects
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Observational Study
There are no comments on this title.
Log in to your account to post a comment.